SAB Biotherapeutics, Inc. (SABSW) operating KPIs

SABSWNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as SABS

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026Score 4/30

$0.01+0.00 (+33.33%)

Close on Oct 20, 2026Market cap $304.80MP/E –Yield –

KPIs

Operating metrics that drive SAB Biotherapeutics's business

Coming soon

This tab will track the numbers specific to SAB Biotherapeutics's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.